Shares of ONXX rose nearly than 100% to 24.15$ after the pharmaceutical company released data from a clinical trial that shows an experimental drug is effective in fighting liver cancer.

Disclaimer : Trading stocks involves risk, this information should not be viewed as trading recommendations.The charts provided here are not meant for investment purposes and only serve as technical examples.

Labels: ONXX